← Scroll for more →
Maxcyte, Inc. (MXCT)
Services-Commercial Physical & Biological Research
Latest Price
$1.59
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.48
P/B Ratio
1.07
Institutional Ownership
57.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 8.20M | $10.0M | 7.73% | -- | 2026-06-30 |
| Vitruvian Partners LLP | 5.04M | $6.0M | 4.75% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.03M | $4.0M | 3.80% | +49.5K | 2026-06-30 |
| Morgan Stanley | 3.69M | $4.0M | 3.48% | +5.9K | 2026-06-30 |
| Mudita Advisors LLP | 3.37M | $4.0M | 3.18% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.06M | $3.0M | 2.88% | -5.74M | 2026-06-30 |
| Brooklands Fund Management Ltd | 2.85M | $3.0M | 2.68% | +658.1K | 2026-06-30 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2.77M | $3.0M | 2.61% | -- | 2026-06-30 |
| Cadian Capital Management, LP | 2.20M | $2.0M | 2.07% | +478.2K | 2026-06-30 |
| Peapod Lane Capital LLC | 2.13M | $2.0M | 2.00% | +793.6K | 2026-06-30 |